A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
Griffith University’s bid to fight the childhood killer pneumonia has received a significant boost following the award of a $304,000 grant from the Bill & Melinda Gates Foundation.